Green Alpha Advisors’s Prime Medicine PRME Stock Holding History

Green Alpha Advisors’s Portfolio PRME Stock Details PRME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$504K	Sell	164,854 -20,169	-11%	-$67K	0.34%	73
2026 Q2	$683K	Sell	185,023 -6,148	-3%	-$20.4K	0.46%	54
2026 Q1	$665K	Buy	191,171 +288	+0.2%	+$1.1K	0.66%	45
2025 Q4	$662K	Buy	190,883 +530	+0.3%	+$2.36K	0.61%	52
2025 Q3	$1.05M	Buy	190,353 +111,359	+141%	+$452K	1.02%	32
2025 Q2	$195K	Sell	78,994 -4,473	-5%	-$6.9K	0.19%	94
2025 Q1	$166K	Buy	83,467 +19,061	+30%	+$48.6K	0.18%	97
2024 Q4	$188K	Buy	+64,406	New	+$226K	0.15%	128
2024 Q3	–	Sell	-26,245	Closed	-$135K	–	143
2024 Q2	$135K	Sell	26,245 -7,493	-22%	-$45.4K	0.11%	127
2024 Q1	$236K	Buy	33,738 +4,200	+14%	+$31.9K	0.17%	128
2023 Q4	$262K	Sell	29,538 -8,277	-22%	-$63.8K	0.19%	138
2023 Q3	$361K	Buy	37,815 +25,429	+205%	+$330K	0.28%	115
2023 Q2	$181K	Buy	+12,386	New	+$173K	0.12%	138

Other funds holding PRME

Concurrent Investment Advisors Tampa, Florida $14.5B AUM 24.52% 1-Year Est. Return

MAM

Milestone Asset Management Pittsburgh, Pennsylvania $631M AUM 19.95% 1-Year Est. Return

Shelton Wealth Management Fort Worth, Texas $254M AUM 22.96% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return

HB Wealth Management Atlanta, Georgia $19.5B AUM 16.96% 1-Year Est. Return

Forum Financial Management Lombard, Illinois $7.7B AUM 11.59% 1-Year Est. Return

SignatureFD Atlanta, Georgia $7.76B AUM 16.09% 1-Year Est. Return

Nisa Investment Advisors St. Louis, Missouri $34.7B AUM 25.93% 1-Year Est. Return

Sterling Capital Management Charlotte, North Carolina $4.92B AUM 24.73% 1-Year Est. Return

Owl Creek Wealth Partners Denver, Colorado $355M AUM

Green Alpha Advisors's PRME Position: Q3 2026 in Review

Green Alpha Advisors reduced its Prime Medicine (PRME) stake by 11% in Q3 2026, selling an estimated $67K and leaving 164,854 shares worth $504K. The position accounts for 0.34% of the portfolio, ranked #73.

Green Alpha Advisors first reported a position in PRME in Q2 2023 and has held it in 13 quarters since. The position peaked at $1.05M in Q3 2025. 18 funds tracked by Wall St. Rank hold PRME as of Q3 2026.

Green Alpha Advisors held 164,854 shares of Prime Medicine worth $504K as of Q3 2026.
Green Alpha Advisors sold 20,169 Prime Medicine shares in Q3 2026, an estimated $67K.
Prime Medicine made up 0.34% of Green Alpha Advisors's portfolio in Q3 2026, its #73 holding.
Green Alpha Advisors first reported a position in Prime Medicine in Q2 2023 and has held it in 13 quarters since.
Green Alpha Advisors's Prime Medicine position peaked at $1.05M in Q3 2025.
18 funds tracked by Wall St. Rank held Prime Medicine as of Q3 2026.

Based on Green Alpha Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.